(secondQuint)Comparing Patient Satisfaction With Pataday or Bepreve.

 5 week randomized study with 15 subjects using Pataday qd for 2 weeks, and the other 15 subjects using Bepreve BID for 2 weeks.

 Following a one-week washout period, the two groups are given the opposite test article (TA) for 2 weeks.

 Subjects to complete daily diary regarding effects of drug and are seen in clinic for 3 exams.

.

 Comparing Patient Satisfaction With Pataday or Bepreve@highlight

The purpose of this study is to compare patient satisfaction with Pataday (Olopatadine hydrochloride 0.

2%) one daily (QD) and Bepreve (Bepotastine besilate ophthalmic solution 1.

5%) two times a day (BID).

